MAT2B-GIT1 interplay activates MEK1/ERK 1 and 2 to induce growth in human liver and colon cancer.
about
Mouse models of liver cancer: Progress and recommendationsStructure and function study of the complex that synthesizesS-adenosylmethionineSignificance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma.S-Adenosylmethionine and methylthioadenosine inhibit β-catenin signaling by multiple mechanisms in liver and colon cancerG-protein-coupled receptor-2-interacting protein-1 is required for endothelial cell directional migration and tumor angiogenesis via cortactin-dependent lamellipodia formationA Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors.The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinomaGIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis.Role of methionine adenosyltransferase α2 and β phosphorylation and stabilization in human hepatic stellate cell trans-differentiationMethionine adenosyltransferase 2B, HuR, and sirtuin 1 protein cross-talk impacts on the effect of resveratrol on apoptosis and growth in liver cancer cells.MiR-138: A promising therapeutic target for cancer.MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4CMiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.Methionine adenosyltransferase 2B-GIT1 complex serves as a scaffold to regulate Ras/Raf/MEK1/2 activity in human liver and colon cancer cells.Arf proteins in cancer cell migration.MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1.Cool-associated Tyrosine-phosphorylated Protein 1 Is Required for the Anchorage-independent Growth of Cervical Carcinoma Cells by Binding Paxillin and Promoting AKT Activation.S-adenosylmethionine and methylthioadenosine inhibit cancer metastasis by targeting microRNA 34a/b-methionine adenosyltransferase 2A/2B axis.Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy.Targeting of GIT1 by miR-149* in breast cancer suppresses cell proliferation and metastasis in vitro and tumor growth in vivo.The Arf-GAP and protein scaffold Cat1/Git1 as a multifaceted regulator of cancer progression.ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.Moderate swimming suppressed the growth and metastasis of the transplanted liver cancer in mice model: with reference to nervous system.Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastases.Antisense Oligonucleotides against miR-21 Inhibit the Growth and Metastasis of Colorectal Carcinoma via the DUSP8 Pathway
P2860
Q26799788-0C42B5B1-E5AF-4E69-B754-374DA503CC95Q27684874-76039AC1-A025-43AB-8B36-7024365B6560Q33803054-92CFC6F2-E89A-459F-8487-D1619A4A2517Q34785481-25925E45-4B64-4514-B288-F59707E2BD31Q34972813-D121F534-E87E-4633-B1F7-18D95A9A83AAQ35716316-BBABCE65-94ED-4B33-9C37-603A8A467345Q36109119-CF758B16-7E63-4FFB-B07D-FD291D257D82Q36399068-9EF910E9-225F-49DF-82E1-3BACF2AFE416Q36546633-1858DABF-11BF-4B7B-8F1B-E1196336B58BQ36820956-1C67E8D2-4E54-47A7-AA4B-F6D4FA33503AQ37095405-591A7BA8-3920-470D-8E95-5EA44205FA7DQ38734800-BB718A57-2748-409C-8260-63C03D9AC0CEQ38842997-BA055E13-5C56-4947-9462-6930C03D7323Q38851568-6473FF13-2419-4DE3-B4A7-EBFD7671D4B6Q38897008-5361DBEB-64FE-48D6-92CA-83C2336E82E5Q38944847-E7BAF262-017E-4922-9FA4-2259FC80D000Q41228798-C8D6C71D-5ED1-4790-9694-DD81C638EDA9Q42803641-2847E1FD-1D5F-4A2E-8F08-CEE93F0D5422Q46237993-38A1EC32-07A1-458E-8776-52FEDA0DA958Q46367509-CF315EC2-728D-424B-A0A0-E49BCA6F7EDFQ47137266-33FB4CD7-BB65-46F9-B15C-2046EEEA45FDQ47693046-1892C015-1A05-4996-82AE-2C6F4061B718Q50534879-2362D1E6-52AC-4482-8EA3-471BABBA0CC8Q52673512-65AB714D-ADDB-4367-A45C-1155CFB57344Q53209146-27118676-D1F8-474F-9E8E-DED0CCA850C4Q54976973-FB841940-98AB-4FA7-9B71-F0C6C1866B09Q57493534-AC1DCEF4-F2BD-40E8-A5BB-6ACC27049EBB
P2860
MAT2B-GIT1 interplay activates MEK1/ERK 1 and 2 to induce growth in human liver and colon cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
MAT2B-GIT1 interplay activates ...... human liver and colon cancer.
@en
type
label
MAT2B-GIT1 interplay activates ...... human liver and colon cancer.
@en
prefLabel
MAT2B-GIT1 interplay activates ...... human liver and colon cancer.
@en
P2093
P2860
P356
P1433
P1476
MAT2B-GIT1 interplay activates ...... human liver and colon cancer.
@en
P2093
Heping Yang
Ivan Tomasi
Jose M Mato
Maria Lauda Tomasi
Pasquale Giordano
Shelly C Lu
Tony W H Li
Yuhua Zheng
P2860
P304
P356
10.1002/HEP.26258
P407
P577
2013-05-14T00:00:00Z